We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KC:NASDAQKingsoft Cloud Holdings Limited Analysis

Data as of 2026-06-29 - not real-time

$8.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Kingsoft Cloud posted a robust revenue surge driven by AI services, outpacing analyst expectations. The top‑line growth is accompanied by a dramatic increase in AI business contribution, now representing a majority of public cloud revenue. Despite the top‑line momentum, profitability remains negative with operating and net margins in the red. Cash generation from operations is strong, yet free cash flow is still negative due to sizable capital expenditures. The balance sheet shows a high leverage profile, with debt far exceeding equity. On the price side, the stock trades well below its DCF‑derived fair value, indicating a large upside potential.
Technical metrics show the short‑term moving average lagging the longer averages, signaling a bearish trend, while the RSI is in the oversold zone. The MACD histogram is negative, reinforcing short‑term downside pressure. Volume has been trending upward, suggesting accumulating interest around current levels. Support sits near the recent low, providing a cushion against further declines. The broader market sentiment is extremely bullish, as reflected by the fear‑greed index. Given the mix of strong growth catalysts and significant risk factors, investors should weigh the upside against the volatility and leverage concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • oversold RSI suggests potential bounce
  • price near support level
  • negative earnings and high leverage

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • sustained AI‑driven revenue growth
  • large valuation gap to fair value
  • strong operating cash flow

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • long‑term cloud market tailwinds in China
  • DCF indicates substantial upside
  • potential improvement in profitability as scale improves

Key Metrics & Analysis

Financial Health

Revenue Growth37.20%
Profit Margin-9.39%
P/E Ratio-91.6
ROE-13.54%
ROA-1.83%
Debt/Equity120.04
P/B Ratio2.0
Op. Cash Flow$4.8B
Free Cash Flow$-2246095872
Industry P/E36.9

Technical Analysis

TrendNeutral
RSI28.6
Support$8.35
Resistance$14.10
MA 20$10.84
MA 50$13.63
MA 200$13.30
MACDBearish
VolumeIncreasing
Fear & Greed Index89.91

Valuation

Fair Value$387.50
Target Price$21.28
Upside/Downside139.05%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta2.03
Volatility64.38%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.